Financials
- Market Capitalization 276.37 M
- Employee 117
- Founded 1999
- CEO N/A
- Website www.niagenbioscience.com
- Headquarter Delaware, United States
- FIGI BBG000BG1J71
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
21
市销率
2.9
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3372 | IRD Opus Genetics, Inc. - Common Stock | 3.49 USD | -1.97% | -14.88% | -10.74% | -6.18% | 284.07 M USD | ||
| 3383 | GLSI Greenwich LifeSciences, Inc. - Common stock | 19.72 USD | +3.73% | +4.50% | -14.41% | +94.67% | 289.45 M USD | ||
| 3405 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.62 USD | +0.56% | -3.98% | -7.18% | +29.29% | 276.80 M USD | ||
| 3411 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.07 USD | +0.49% | 0.00% | +23.95% | +15.00% | 273.31 M USD |